Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05025397 · ClinicalTrials.gov registry record · Phase 1
A Study of Danavorexton in Anesthetized Adults
A Phase 1 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT05025397 is a Phase 1 study that has completed, run by Takeda. The registered enrollment target is 28 participants.
The verdict
NCT05025397, a Phase 1 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The aims of the study are: * to assess the safety profile of danavorexton when it is administered with anesthetics. * to learn what effect danavorexton has on anesthetized adults. On Day 1, participants will receive a single intravenous (IV) infusion of danavorexton or a placebo after participants have been anesthetized for about 40 minutes. Clinic doctors will arrange a follow-up visit by phone or video on Day 7.
Interventions
- DRUG Sevoflurane
- DRUG Propofol
- DRUG Danavorexton
- DRUG Danavorexton Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2021-09-28 |
| Est. Completion | 2022-03-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05025397
The ClinicalTrials.gov registry entry for NCT05025397 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Sevoflurane is the first listed.
NCT05025397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05025397 about?
NCT05025397 is a clinical study titled "A Study of Danavorexton in Anesthetized Adults". The aims of the study are: * to assess the safety profile of danavorexton when it is administered with anesthetics. * to learn what effect danavorexton has on anesthetized adults. On Day 1, participants will receive a single intravenous (IV) infusion of danavorexton or a placebo after participants...
What is the current status of trial NCT05025397?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2021-09-28. Estimated completion is 2022-03-08.
What interventions are being tested in trial NCT05025397?
The interventions under investigation include: Sevoflurane (DRUG), Propofol (DRUG), Danavorexton (DRUG), Danavorexton Placebo (DRUG).
Who is sponsoring clinical trial NCT05025397?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.